Kathy A. Aldern

1.5k total citations
42 papers, 1.2k citations indexed

About

Kathy A. Aldern is a scholar working on Epidemiology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Kathy A. Aldern has authored 42 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Epidemiology, 12 papers in Infectious Diseases and 12 papers in Molecular Biology. Recurrent topics in Kathy A. Aldern's work include Cytomegalovirus and herpesvirus research (12 papers), Herpesvirus Infections and Treatments (11 papers) and HIV/AIDS drug development and treatment (11 papers). Kathy A. Aldern is often cited by papers focused on Cytomegalovirus and herpesvirus research (12 papers), Herpesvirus Infections and Treatments (11 papers) and HIV/AIDS drug development and treatment (11 papers). Kathy A. Aldern collaborates with scholars based in United States, Canada and Belgium. Kathy A. Aldern's co-authors include Karl Y. Hostetler, James R. Beadle, Peter J. Hornsby, Sandra E. Harris, Earl R. Kern, George R. Painter, William Wan, Caroll B. Hartline, Emma A. Harden and Natalie Rodríguez and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Clinical Endocrinology & Metabolism and Biochemical and Biophysical Research Communications.

In The Last Decade

Kathy A. Aldern

42 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kathy A. Aldern United States	20	593	382	368	312	190	42	1.2k
Olaf Weber Germany	18	733 1.2×	240 0.6×	191 0.5×	201 0.6×	166 0.9×	34	1.3k
A.S. Tyms United Kingdom	23	477 0.8×	312 0.8×	575 1.6×	223 0.7×	73 0.4×	51	1.5k
Ronna E. Dornsife United States	16	559 0.9×	613 1.6×	412 1.1×	426 1.4×	117 0.6×	25	1.4k
Niklaus H. Mueller United States	13	291 0.5×	202 0.5×	235 0.6×	168 0.5×	44 0.2×	29	913
Wayne H. Miller United States	26	1.3k 2.1×	1.2k 3.1×	1.1k 3.0×	740 2.4×	216 1.1×	50	2.9k
John J. Docherty United States	19	569 1.0×	116 0.3×	297 0.8×	50 0.2×	177 0.9×	49	1.2k
Joseph F. Cortese United States	20	338 0.6×	382 1.0×	510 1.4×	72 0.2×	114 0.6×	26	2.7k
William D. Tolbert United States	24	117 0.2×	173 0.5×	650 1.8×	387 1.2×	129 0.7×	59	1.3k
Angela K. Talley United States	14	283 0.5×	272 0.7×	270 0.7×	117 0.4×	65 0.3×	26	1.9k
Elisa Nemes South Africa	22	447 0.8×	731 1.9×	402 1.1×	206 0.7×	54 0.3×	58	1.6k

Countries citing papers authored by Kathy A. Aldern

Since Specialization

Citations

This map shows the geographic impact of Kathy A. Aldern's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathy A. Aldern with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathy A. Aldern more than expected).

Fields of papers citing papers by Kathy A. Aldern

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathy A. Aldern. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathy A. Aldern. The network helps show where Kathy A. Aldern may publish in the future.

Co-authorship network of co-authors of Kathy A. Aldern

This figure shows the co-authorship network connecting the top 25 collaborators of Kathy A. Aldern. A scholar is included among the top collaborators of Kathy A. Aldern based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathy A. Aldern. Kathy A. Aldern is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Valiaeva, Nadejda, et al.. (2010). Antiproliferative Effects of Octadecyloxyethyl 9-[2-(Phosphonomethoxy)Ethyl]Guanine against Me-180 Human Cervical Cancer Cells in vitro and in vivo. Chemotherapy. 56(1). 54–59. 5 indexed citations

Painter, George R., Merrick R. Almond, Lawrence C. Trost, et al.. (2007). Evaluation of Hexadecyloxypropyl-9- R -[2-(Phosphonomethoxy)Propyl]-Adenine, CMX157, as a Potential Treatment for Human Immunodeficiency Virus Type 1 and Hepatitis B Virus Infections. Antimicrobial Agents and Chemotherapy. 51(12). 4538–4538. 3 indexed citations

Magee, Wendy C., Kathy A. Aldern, Karl Y. Hostetler, & David H. Evans. (2007). Cidofovir and (S)-9-[3-Hydroxy-(2-Phosphonomethoxy)Propyl]Adenine Are Highly Effective Inhibitors of Vaccinia Virus DNA Polymerase When Incorporated into the Template Strand. Antimicrobial Agents and Chemotherapy. 52(2). 586–597. 72 indexed citations

Hostetler, Karl Y., James R. Beadle, Kathy A. Aldern, et al.. (2006). Oral 1-O-octadecyl-2-O-benzyl-sn-glycero-3-cidofovir targets the lung and is effective against a lethal respiratory challenge with ectromelia virus in mice. Antiviral Research. 73(3). 212–218. 24 indexed citations

Hostetler, Karl Y., et al.. (2006). Enhanced antiproliferative effects of alkoxyalkyl esters of cidofovir in human cervical cancer cells in vitro. Molecular Cancer Therapeutics. 5(1). 156–159. 18 indexed citations

Valiaeva, Nadejda, et al.. (2006). Synthesis and antiviral evaluation of alkoxyalkyl esters of acyclic purine and pyrimidine nucleoside phosphonates against HIV-1 in vitro. Antiviral Research. 72(1). 10–19. 28 indexed citations

Cheng, Lingyun, Karl Y. Hostetler, Hyoung Jun Koh, et al.. (2004). Characterization of a Novel Intraocular Drug-Delivery System Using Crystalline Lipid Antiviral Prodrugs of Ganciclovir and Cyclic Cidofovir. Investigative Ophthalmology & Visual Science. 45(11). 4138–4138. 35 indexed citations

Aldern, Kathy A., et al.. (2003). Increased Antiviral Activity of 1-O-Hexadecyloxypropyl-[2-14C]cidofovir in MRC-5 Human Lung Fibroblasts Is Explained by Unique Cellular Uptake and Metabolism. Molecular Pharmacology. 63(3). 678–681. 110 indexed citations

Cheng, Lingyun, Karl Y. Hostetler, James R. Beadle, et al.. (2003). Ganciclovir Release Rates in Vitreous from Different Formulations of 1- O -Hexadecylpropanediol-3-Phospho-Ganciclovir. Journal of Ocular Pharmacology and Therapeutics. 19(2). 161–169. 5 indexed citations

10.

Hostetler, Karl Y., Jennifer Hammond, Ganesh D. Kini, et al.. (2000). In vitro Anti-HIV-1 Activity of sn -2-Substituted 1-O-Octadecyl- sn -Glycero-3-Phosphonoformate Analogues and Synergy with Zidovudine. Antiviral chemistry & chemotherapy. 11(3). 213–219. 7 indexed citations

11.

Beadle, James R., Ganesh D. Kini, Kathy A. Aldern, et al.. (2000). Synthesis and Antiviral Evaluation of 1-O-Hexadecylpropanediol-3-P-acyclovir: Efficacy Against HSV-1 Infection in Mice. Nucleosides Nucleotides & Nucleic Acids. 19(1-2). 471–479. 14 indexed citations

12.

Taşkintuna, İbrahim, Alay Banker, Marisa Flores-Aguilar, et al.. (1997). EVALUATION OF A NOVEL LIPID PRODRUG FOR INTRAOCULAR DRUG DELIVERY. Retina. 17(1). 57–64. 13 indexed citations

13.

Kini, Ganesh D., et al.. (1997). Synthesis and antiviral activity of 1-O-octadecyl-2-O-alkyl-sn-glycero-3-foscarnet conjugates in human cytomegalovirus-infected cells. Antiviral Research. 36(2). 115–124. 12 indexed citations

14.

Reasor, Mark J., et al.. (1996). Comparative evaluation of amiodarone-induced phospholipidosis and drug accumulation in Fischer-344 and Sprague-Dawley rats. Toxicology. 106(1-3). 139–147. 28 indexed citations

15.

Hostetler, Karl Y., Michael F. Gardner, & Kathy A. Aldern. (1991). [11] Assay of phospholipases C and D in presence of other lipid hydrolases. Methods in enzymology on CD-ROM/Methods in enzymology. 197. 125–134. 10 indexed citations

16.

Hostetler, Karl Y., et al.. (1991). Effect of amiodarone on the phospholipid and lamellar body content of lymphoblasts in vitro and peripheral blood lymphocytes in vivo. Biochemical Pharmacology. 41(6-7). 1007–1013. 12 indexed citations

17.

Hornsby, Peter J., Kathy A. Aldern, & Sandra E. Harris. (1986). Methylcholanthrene: A possible pseudosubstrate for adrenocortical 17α-hydroxylase and aryl hydrocarbon hydroxylase. Biochemical Pharmacology. 35(19). 3209–3219. 9 indexed citations

18.

Hornsby, Peter J., Kathy A. Aldern, & Sandra E. Harris. (1985). Mode of action of butylated hydroxyanisole (BHA) and other phenols in preventing loss of 11β-hydroxylase activity in cultured bovine adrenocortical cells. Biochemical Pharmacology. 34(6). 865–872. 10 indexed citations

19.

Hornsby, Peter J., Sandra E. Harris, & Kathy A. Aldern. (1984). Mode of action of sulfoxides in preventing loss of activity of 11β-hydroxylase in cultured bovine adrenocortical cells. Chemico-Biological Interactions. 51(3). 335–346. 11 indexed citations

20.

Hornsby, Peter J. & Kathy A. Aldern. (1984). Steroidogenic Enzyme Activities in Cultured Human Definitive Zone Adrenocortical Cells: Comparison with Bovine Adrenocortical Cells and Resultant Differences in Adrenal Androgen Synthesis*. The Journal of Clinical Endocrinology & Metabolism. 58(1). 121–127. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact